# Immune Biomarkers Related to Bone Pathology in Patients With Type 1 Gaucher Disease

> **NCT04055831** · — · UNKNOWN · sponsor: **Lysosomal and Rare Disorders Research and Treatment Center, Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Gaucher Disease Type 1

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04055831
- **Lead sponsor:** Lysosomal and Rare Disorders Research and Treatment Center, Inc.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-15
- **Primary completion:** 2020-04-15
- **Final completion:** 2020-05-15
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04055831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04055831, "Immune Biomarkers Related to Bone Pathology in Patients With Type 1 Gaucher Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04055831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*